Replacing Lu-177 with Tb-161 in DOTA-TATE and PSMA-617 therapy: potential dosimetric implications for activity selection.

Verburg, Frederik A; de Blois, Erik; Koolen, Stijn; Konijnenberg, Mark W

Verburg, Frederik A; de Blois, Erik; Koolen, Stijn; Konijnenberg, Mark W.

Afiliación

Verburg FA; Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Dr Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. f.verburg@erasmusmc.nl.
de Blois E; Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Dr Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
Koolen S; Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Dr Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
Konijnenberg MW; Department of Hospital Pharmacy, Erasmus MC, Rotterdam, The Netherlands.

EJNMMI Phys ; 10(1): 69, 2023 Nov 10.

Article en En | MEDLINE | ID: mdl-37947917

Palabras clave

Dosimetry; Radionuclide therapy; Terbium-161; [177Lu]Lu-DOTA-TATE; [177Lu]Lu-PSMA-617

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: EJNMMI Phys Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google